St Jude Medical
STJ
STJ was delisted on the 4th of January, 2017.
555 hedge funds and large institutions have $17.2B invested in St Jude Medical in 2014 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 170 increasing their positions, 226 reducing their positions, and 61 closing their positions.
194% more call options, than puts
Call options by funds: $173M | Put options by funds: $58.6M
8% more capital invested
Capital invested by funds: $15.9B → $17.2B (+$1.33B)
0% more funds holding in top 10
Funds holding in top 10: 11 → 11 (0)
10% less first-time investments, than exits
New positions opened: 55 | Existing positions closed: 61
2% less funds holding
Funds holding: 565 → 555 (-10)
25% less repeat investments, than reductions
Existing positions increased: 170 | Existing positions reduced: 226
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$380M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$187M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$140M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$73.6M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$60.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCI
Columbus Circle Investors
|
-$127M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$124M |
| 3 |
Millennium Management
New York
|
-$85.8M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$51.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$48.3M |
STJ Hedge Fund Activity: Q2 2014 in Review
555 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q2 2014, worth a combined $17.2B — up 8.4% from $15.9B a quarter earlier.
Sellers outnumbered buyers: 61 funds closed out of STJ and 55 opened new positions — a net loss of 6 holders — while 226 trimmed existing stakes and 170 added.
The largest buyer was Capital Research Global Investors, adding an estimated $380M. The largest seller was Columbus Circle Investors, exiting entirely with an estimated $127M sold.
- 555 institutional investors held St Jude Medical (STJ) as of Q2 2014, down from 565 in Q1 2014.
- Funds reported $17.2B of St Jude Medical stock for Q2 2014, up 8.4% quarter-over-quarter.
- 55 funds opened new St Jude Medical positions in Q2 2014 and 61 closed out, a net change of -6 holders.
- The largest St Jude Medical buyer in Q2 2014 was Capital Research Global Investors, an estimated $380M added.
- The largest St Jude Medical seller in Q2 2014 was Columbus Circle Investors, an estimated $127M sold.
Based on aggregated 13F filings for Q2 2014.